» Articles » PMID: 8259744

Iron Status in Danish Women Aged 35-65 Years. Relation to Menstruation and Method of Contraception

Overview
Publisher Wiley
Date 1993 Nov 1
PMID 8259744
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Iron status was assessed by serum (S-) ferritin and hemoglobin (Hb) in a population survey comprising 883 non-gravid Danish women in age cohorts of 35, 45, 55, and 65 years. Premenopausal women (n = 676) had lower S-ferritin, median 42 micrograms/l, than postmenopausal women (n = 207), median 80 micrograms/l (p < 0.0001). Of premenopausal women, 12.1% had S-ferritin < or = 20 micrograms/l (i.e. depleted iron stores), and 35.6% S-ferritin of 21-40 micrograms/l (i.e. small iron stores). Corresponding figures in postmenopausal women were 0.5% and 13.2%. Premenopausal blood donors (n = 88) had lower S-ferritin than non-donors (p < 0.001). In premenopausal women, S-ferritin levels were strongly dependent on the duration of menstrual bleeding (p < 0.0001), which in turn was related to the method of contraception. Women (n = 64) using hormonal contraceptives (the pill) had menstrual bleeding of shorter duration than those (n = 511) not using pills or intrauterine devices (IUD), who in turn had bleeding of shorter duration than those (n = 101) using IUD. Median S-ferritin in pill users was 62 micrograms/l, in those not using pills or IUD 42 micrograms/l, and in IUD users 36 micrograms/l. S-ferritin values < 40 micrograms/l (i.e. small and depleted iron stores) were seen in 25% of pill users, in 48% of those not using pills or IUD, and in 61% of IUD users.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Menstrual blood loss is an independent determinant of hemoglobin and ferritin levels in premenopausal blood donors.

Ekroos S, Karregat J, Toffol E, Castren J, Arvas M, van den Hurk K Acta Obstet Gynecol Scand. 2024; 103(8):1645-1656.

PMID: 38856303 PMC: 11266725. DOI: 10.1111/aogs.14890.


Effects of antiplatelet therapy on menstrual blood loss in reproductive-aged women: a systematic review.

Kempers E, van der Zande J, Janssen P, Cornette J, Roos-Hesselink J, Kruip M Res Pract Thromb Haemost. 2024; 8(1):102295.

PMID: 38268520 PMC: 10805676. DOI: 10.1016/j.rpth.2023.102295.


Does chronic oral contraceptive use detrimentally affect C-reactive protein or iron status for endurance-trained women?.

Badenhorst C, Govus A, Mundel T Physiol Rep. 2023; 11(14):e15777.

PMID: 37487629 PMC: 10365947. DOI: 10.14814/phy2.15777.


Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review.

Tekle E, Gelaw Y, Asrie F J Blood Med. 2022; 13:525-536.

PMID: 36199529 PMC: 9528910. DOI: 10.2147/JBM.S379841.


Iron-Containing Oral Contraceptives and Their Effect on Hemoglobin and Biomarkers of Iron Status: A Narrative Review.

Fischer J, Sasai C, Karakochuk C Nutrients. 2021; 13(7).

PMID: 34371850 PMC: 8308850. DOI: 10.3390/nu13072340.